Press release -
Meet Vironova at Bioprocessing Summit Europe 2019
Meet Vironova at Bioprocessing Summit Europe 2019 on March 19-21 in Lisbon, Portugal. Vironova’s Marketing Director Nina Forsberg will host and moderate a Round table session on the 19th of March at 16:45 on the topics and needs for analytical methods in gene therapy vector characterization.
Also covered will be the challenges in meeting regulatory and safety requirements in emerging therapies such as gene therapy:
- Current CMC guidelines – strengths and limitations and need for further detail
- How to interpret and correlate data from different analytical methods – are established methods sufficient or are novel analytical solutions needed?
- Risks to consider when relying on traditional methods versus investing in innovative technology – choosing the right collaborations partner.
Insight are free, but seats are limited, make sure to be there early!
Our Senior Scientist and Ph. D. Vanessa Carvalho will hold a presentation on March 20th, at 15:15 on the topic Analysis of Purity and Packaging of Gene Therapy Vectors and VLPs to Support Process Development Decisions. Make sure to attend and learn.
Meet up with us to share your impressions, insights and challenges at our booth. You will find our European Sales Development Managers Bas Hersmus and Beata Hadavan; Marketing Director Nina Forsberg; and Vironova Biosafety’s Director Lennart Lindquist. Vironova’s Electron Microscopy Services representative at the Summit is Vanessa Carvalho.
Last but not least, check out MiniTEM™ at our booth. A compact and portable TEM, designed for automated nanoparticle characterization Built by experts for everyday users. Bringing software, AI, Big Data and Life Science data into the equation.
Contacts for more information and information to match your need:
- Round table-related questions – nina.forsberg@vironova.com
- Presentation-related questions – vanessa.carvalho@vironova.com
- Biosafety-related questions – lennart.lindqvist@vironova.com
- MiniTEM-related questions – bas.hersmus@vironova
- Electron Microscopy Services-related questions – beata.hadavan@vironova.com
Related links
Topics
- Medical research
Categories
- vironova
- minitem
- em services
Vironova is a Swedish biotechnology company providing comprehensive, hardware, software and services for the analysis of nanoparticles. Vironova revolutionizes access to transmission electron microscopy (TEM)-based image analysis in biopharmaceutical development. Our solution enables automated analyses for faster and better-informed decisions to secure robust bioprocessing and final product quality.
The Vironova offering comprises:
- Cost effective, fast Electron Microscopy (EM) services enabled by the in-house developed Vironova Analyzing Software (VAS) designed for semi-automated nanoparticle analysis
- Viral clearance testing performed in GLP and BSLIII certified laboratories
- MiniTEM™, a bench-top Transmission Electron Microscope system designed for automated nanoparticle characterization. High-resolution images reveal particle morphologies that are transformed into accurate metrics.
